Articles by Bruce Meiklejohn - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Bruce Meiklejohn

Bruce Meiklejohn


Bruce Meiklejohn is a principal fellow, regulatory COE-biotech at Eli Lilly and Company

Articles
Quality by Design for Biotechnology Products—Part 3
January 1, 2010

Regulatory flexibility can make continuous improvement possible.

Quality by Design for Biotechnology Products—Part 2
December 1, 2009

Second in a three-part series that discusses the complexities of QbD implementation in biotech development.

Quality by Design for Biotechnology Products—Part 1
November 1, 2009

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.

ADVERTISEMENT

ADVERTISEMENT

Click here